Professor Alex Horsley
Chairman
Alex is a Professor of Respiratory Medicine at the University of Manchester, consultant at the Manchester Adult Cystic Fibrosis (CF) Centre, and CF academic lead for the NIHR Manchester Biomedical Research Centre (BRC). He is director of the NIHR Manchester Clinical Research Facility at Wythenshawe Hospital, where he oversees trials activity in a wide range of specialties. Alex is also the chair of CF Trust Clinical Trials Accelerator Platform, chair of the NIHR Respiratory Translational Research Collaboration, and CF specialty lead for the NIHR Clinical Research Network.
He is responsible for initiating and maintaining one of the largest CF trials programs in the country, having led >25 trials of new therapies in CF since 2012 and making Manchester one of the leading sites for CF clinical trials internationally. He has been national or global lead on trials of several ground-breaking therapies, including transformative new CFTR modulator therapies. He has experience at all phases of clinical trials and has also helped design and deliver clinical trials in acute COVID-19.